Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma

Cancer Research

Volumn 72, Issue 6, 2012, Pages 1353-1362

  Haseley, Amy ^a   Boone, Sean ^a   Wojton, Jeffrey ^a   Yu, Lianbo ^a   Yoo, Ji Young ^a   Yu, Jianhua ^a   Kurozumi, Kazuhiko ^c   Glorioso, Joseph C ^d   Caligiuri, Michael A ^a,b   Kaur, Balveen ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; GAMMA INTERFERON; JANUS KINASE; ONCOLYTIC VIRUS; STAT PROTEIN; VERY LATE ACTIVATION ANTIGEN 6;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL DESTRUCTION; UPREGULATION; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYSTEINE-RICH PROTEIN 61; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; INTEGRIN ALPHA6BETA1; INTERFERON TYPE I; INTERFERON-ALPHA; MICE; MICE, NUDE; ONCOLYTIC VIROTHERAPY; SIGNAL TRANSDUCTION;

EID: 84863290576     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2526     Document Type: Article

References (46)

1. Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007;25:4127-36. (Pubitemid 47492957)
2. Kaur B, Cripe TP, Chiocca EA. "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment. Curr Gene Ther 2009;9:341-55.
3. Kurozumi K, Hardcastle J, Thakur R, Shroll J,Nowicki M, Otsuki A, et al. Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61. Mol Ther 2008;16:1382-91.
4. Chen Y, Du XY. Functional properties and intracellular signaling of CCN1/Cyr61. J Cell Biochem 2007;100:1337-45. (Pubitemid 46515568)
5. Yang GP, Lau LF. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991;2:351-7.
6. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009;41:771-83.
7. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004;10:2072-81. (Pubitemid 38375569)
8. Hong Y, Ho KS, Eu KW, Cheah PY. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res 2007;13:1107-14. (Pubitemid 46424049)
9. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, et al. Cyr61 is over-expressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 2004;64:1987-96. (Pubitemid 38339444)
10. Kim SM, Park JH, Chung SK, Kim JY, Hwang HY, Chung KC, et al. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol 2004;78:13479-88.
11. Dorn A, Zhao H, Granberg F, Hosel M, Webb D, Svensson C, et al. Identification of specific cellular genes up-regulated late in adenovirus type 12 infection. J Virol 2005;79:2404-12. (Pubitemid 40204595)
12. Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, et al. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection. J Virol 2010;84:12200-9.
13. Kaur B, Brat DJ, Devi NS, Van Meir EG. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 2005;24:3632-42. (Pubitemid 40756232)
14. Terada K, Wakimoto H, Tyminski E, Chiocca EA, Saeki Y. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther 2006;13:705-14.
15. Wakimoto H, Fulci G, Tyminski E, Chiocca EA. Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis. Gene Ther 2004;11:214-23. (Pubitemid 38159694)
16. Yoo JY, Haseley A, Bratasz A, Chiocca EA, Zhang J, Powell K, et al. Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Mol Ther 2012;20:287-97.
17. Yoo JY, Kim JH, Kim J, Huang JH, Zhang SN, Kang YA, et al. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther 2008;15:635-51. (Pubitemid 351524518)
18. Kim KH, Min YK, Baik JH, Lau LF, Chaqour B, Chung KC. Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor. J Biol Chem 2003;278:13847-54. (Pubitemid 36799923)
19. Quan T, Qin Z, Xu Y, He T, Kang S, Voorhees JJ, et al. Ultraviolet irradiation induces CYR61/CCN1, a mediator of collagen homeostasis, through activation of transcription factor AP-1 in human skin fibroblasts. J Invest Dermatol 2010;130:1697-706.
20. Spencer VA, Xu R, Bissell MJ. Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. Adv Cancer Res 2007;97:275-94. (Pubitemid 46528992)
21. Suh HS, Choi S, Khattar P, Choi N, Lee SC. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol 2010;5:521-32.
22. Otsuki A, Patel A, Kasai K, Suzuki M, Kurozumi K, Chiocca EA, et al. Histone deacetylase inhibitors augment antitumor efficacy of herpesbased oncolytic viruses. Mol Ther 2008;16:1546-55.
23. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 2002;277:46248-55. (Pubitemid 35417617)
24. Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 2001;276:10443-52.
25. Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, Lau LF. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 2002;143:1441-50. (Pubitemid 34274374)
26. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010;6:421-32.
27. Quan WY, Ko JA, Yanai R, Nakamura Y, Nishida T. Integrin-mediated inhibition of interleukin-8 secretion from human neutrophils by collagen type I. J Leukoc Biol 2009;87:487-91.
28. Mousa SA, Lorelli W, Campochiaro PA. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem 1999;74:135-43. (Pubitemid 29270036)
29. Hammar E, Tomas A, Bosco D, Halban PA. Role of the Rho-ROCK (Rho-associated kinase) signaling pathway in the regulation of pancreatic beta-cell function. Endocrinology 2009;150:2072-9.
30. Bosco D, Meda P, Halban PA, Rouiller DG. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes 2000;49:233-43. (Pubitemid 30071002)
31. Parnaud G, Hammar E, Rouiller DG, Armanet M, Halban PA, Bosco D. Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix. Diabetes 2006;55:1413-20. (Pubitemid 44195381)
32. Alain T, Lun X, Martineau Y, Sean P, Pulendran B, Petroulakis E, et al. Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production. Proc Natl Acad Sci U S A 2010;107:1576-81.
33. Wollmann G, Robek MD, van den Pol AN. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. J Virol 2007;81:1479-91. (Pubitemid 46167869)
34. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992;52:2523-9.
35. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: A new class of inflammation modulators? Biochimie 2011;93:377-88.
36. Dhar A, Ray A. The CCN family proteins in carcinogenesis. Exp Oncol 2010;32:2-9.
37. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, et al. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 2001;276:14187-94.
38. Sun ZJ, Wang Y, Cai Z, Chen PP, Tong XJ, Xie D. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer 2008;99:1656-67.
39. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 2005;11:7243-54. (Pubitemid 41507681)
40. Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY, et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2007;2:e534.
41. Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, et al. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 2004;279:53087-96. (Pubitemid 40051809)
42. Maeta N, Osaki M, Shomori K, Inaba A, Kidani K, Ikeguchi M, et al. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma. Oncology 2007;73:118-26. (Pubitemid 351465610)
43. Thomis DC, Samuel CE. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J Virol 1993;67:7695-700. (Pubitemid 23343908)
44. Cassady KA, Gross M, Roizman B. The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol 1998;72:7005-11. (Pubitemid 28377827)
45. Altaner C. Glioblastoma and stem cells. Neoplasma 2008;55:369-74.
46. Delamarre E, Taboubi S, Mathieu S, Berenguer C, Rigot V, Lissitzky JC, et al. Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells. Am J Pathol 2009;175:844-55.